Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Spina Bifida Occulta

ClinicalTrials.gov lists 3 trials for Spina Bifida Occulta or a narrower condition beneath it.

MeSH D016136 Nervous System Diseases C10 C16 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 2 Phase 2 1 Not applicable Not applicable 1 Observational Observational 1 Phase 2 Phase 2 1 Not applicable Not applicable 1 Observational Observational 1

Trials per phase

3 of the 3 trials are tagged with Spina Bifida Occulta itself; the rest are tagged with a narrower condition beneath it.

Get the Spina Bifida Occulta report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Spina Bifida Occulta trials start? (3)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 2
  • Not applicable
  • Observational

Top of scale: 1

2012: 1 trials (Phase 2 1) 2017: 1 trials (Observational 1) 2022: 1 trials (Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2022 1
2017 1
2012 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Spina Bifida Occulta trials in? (3)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 2 1
Not applicable 1
Observational 1

How many Spina Bifida Occulta trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1
Completed 1
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which publications cover Spina Bifida Occulta? (14)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Spondylolysis and spina bifida occulta in pediatric patients: prevalence study using computed tomography as a screening method. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2016 Yes
Nocturnal enuresis with spina bifida occulta: Does it interfere behavioral management success? International urology and nephrology 2015 Yes
The adverse influence of spina bifida occulta on the medical treatment outcome of primary monosymptomatic nocturnal enuresis. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 2014 Yes
Location of spina bifida occulta and ultrasonographic bladder abnormalities predict the outcome of treatment for primary nocturnal enuresis in children. International journal of urology : official journal of the Japanese Urological Association 2007 Yes
Spina bifida outcome: a 25-year prospective. Pediatric neurosurgery 2001 Yes

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Closed spinal dysraphism 645202 Exact Orphadata Science knowledge files, Product 1
Closed spinal dysraphism 645202 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages